In this edition:
BOSS: surveillance vs. at-need endoscopy for Barrett’s oesophagus
GLADIATOR: etrasimod in mild to moderate UC
ADDapt: a low emulsifier diet in mild to moderate Crohn’s disease
REScUE: intensified Ustekinumab re-induction after secondary loss of response in Crohn’s disease
DEGAS: dupilumab in eosinophilic gastritis
NRT-MISO: misoprostol + lansoprazole in idiopathic gastroduodenal ulcers
Changyanning tablets for diarrhoea-predominant IBS
Rifaximin + N-acetylcysteine in diarrhoea-predominant IBS
Gallstones with GLP-1 agonists in type 2 diabetes
Risks of digestive diseases with physical activity
Please login below to download this issue (PDF)